| dc.contributor.author | Drysdale, K | en_US |
| dc.contributor.author | Townley, C | en_US |
| dc.contributor.author | Mahomed, F | en_US |
| dc.contributor.author | Foster, G | en_US |
| dc.date.accessioned | 2020-07-09T15:18:27Z | |
| dc.date.issued | 2019-04 | en_US |
| dc.identifier.issn | 0168-8278 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65593 | |
| dc.format.extent | E131 - E131 | en_US |
| dc.language.iso | en | en_US |
| dc.title | Effectiveness of therapy in 16, 567 directly-acting antiviral treated people in England: high response rates in genotype 3 hepatitis C infection regardless of degree of fibrosis, but ribavirin improves response in cirrhosis | en_US |
| dc.type | Conference Proceeding | |
| dc.rights.holder | © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. | |
| dc.identifier.doi | 10.1016/S0618-8278(19)30231-2 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481700232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 70 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
